TXG
10x Genomics, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$81.55
−2.48%Oct 13, 2026, 20:05 UTC
10x Genomics, Inc. announced it will report financial results for the third quarter ended September 30, 2026, after market close on November 5, 2026.
Source:Oct 7, 2026, 13:00 UTC
10x Genomics, Inc. announced a multi-project research collaboration with Fred Hutchinson Cancer Research Center to advance single-cell and spatial technology applications in solid tumors and blood cancers.
Source:Sep 30, 2026, 17:11 UTC
10x Genomics began shipments of its Atera spatial biology platform, with orders topping 40 systems.
Source:Sep 29, 2026, 13:01 UTC
10x Genomics announced Sentira, a new cloud analysis platform, beginning with Sentira Spatial Analysis, which uses NVIDIA accelerated computing to cut spatial data processing times from hours to minutes.
Source:Sep 10, 2026, 13:00 UTC
Lunit announced that 10x Genomics will incorporate Lunit's AI-powered pathology platform Lunit SCOPE IO into its oncology biomarker discovery workflow.
Source:Aug 28, 2026, 18:39 UTC
10x Genomics won a patent infringement lawsuit judgment against Parse Biosciences.
Aug 7, 2026, 16:00 UTC
10x Genomics announced multi-year research collaborations with Cleveland Clinic and Lausanne University Hospital to advance diagnostic applications of single-cell and spatial biology.
Source:Aug 6, 2026, 20:02 UTC
10x Genomics reported its financial results for the second quarter ended June 30, 2026, on August 6, 2026.
Jul 29, 2026, 13:00 UTC
10x Genomics announced a research collaboration with Lausanne University Hospital to advance diagnostic applications of single cell and spatial technologies for cancer care.
Source:Jun 19, 2026, 15:36 UTC
10x Genomics and Cleveland Clinic collaborate to advance bladder cancer diagnostics using Flex Apex, Xenium, and potentially Atera.
Source:Jun 17, 2026, 13:00 UTC
10x Genomics and Cleveland Clinic announced a research collaboration to advance diagnostic applications of single cell and spatial technologies in bladder cancer patients.
Source:Jun 9, 2026, 13:17 UTC
10x Genomics acquires Proteintech Genomics.